Prev Chronic Dis by Koh, Howard K. et al.
PREVENTING  CHRONIC  DISEASE
P U B L I C  H E A L T H  R E S E A R C H ,  P R A C T I C E ,  A N D  P O L I C Y 





Toward an Integrated Public Health






Suggested  citation  for  this  article:  Koh HK,  Kobau R,
Whittemore VH, Mann MY, Johnson JG, Hutter JD, et al.  Toward
an Integrated Public Health Approach for Epilepsy in the 21st




Epilepsy, a complex spectrum of disorders, merits enhanced pub-
lic health action.  In 2012, the Institute of Medicine (IOM) re-
leased a seminal report on the public health dimensions of the epi-
lepsies, recommending actions in 7 domains. The report urged a
more integrated and coordinated national approach for care center-
ing on the whole patient, including heightened attention to comor-
bidities and quality of life; more timely referral and access to treat-
ments; and improved community resources, education, stakehold-
er collaboration, and public communication. The US Department
of Health and Human Services responded to this report by acceler-
ating and integrating ongoing initiatives and beginning new ones.
This article summarizes recent federally supported activities pro-
moting an integrated public health approach for epilepsy, high-
lighting progress in response to the landmark 2012 IOM report
and identifying opportunities for continued public health action.
Introduction and Background
Despite being recognized for millennia, epilepsy is poorly under-
stood by the public today. Epilepsy represents a complex spec-
trum of disorders that varies by type, cause, severity, and impact
(1,2). Epilepsy can not only shorten life but also severely com-
promise overall well-being and full participation in life activities
(1–3). Hence, epilepsy is not just a trying neurological disorder for
individuals but also a broader public health challenge for society
(1,4–7). This article summarizes federally supported activities pro-
moting an integrated public health approach for epilepsy, high-
lighting recent progress in response to the landmark 2012 Institute
of Medicine (IOM) report, Epilepsy Across the Spectrum: Promot-
ing Health and Understanding (2).
Some national efforts previously spurred planning to address epi-
lepsy in the United States. For example, in 1975, the Plan for Na-
tionwide Action on Epilepsy, commissioned by Congress and led
by the  former  Department  of  Health,  Education,  and Welfare,
identified the burden of epilepsy in the population and released a
first set of groundbreaking recommendations to federal and state
agencies (5). Later, 2 national conferences, Living Well with Epi-
lepsy I (1997) and Living Well with Epilepsy II (2003), convened
an expanded group of stakeholders to assess progress and gaps for
continued public health action (7). Recommendations from these
latter initiatives guided some federal agencies and epilepsy stake-
holder activities in areas such as surveillance (2), but broader at-
tention was needed.
To reinvigorate efforts to unify action in the 21st century, 24 or-
ganizations, including federal agencies in the US Department of
Health and Human Services (HHS) and nonprofit organizations in
Vision 20–20 (a group of  epilepsy stakeholder  organizations),
joined together in 2010 to commission the first epilepsy report
from the  IOM. After  receiving input  through public  meetings
across the country and from health professional boards and associ-
ations, the IOM created a roadmap for the future. In March 2012,
the IOM unveiled its  seminal  publication Epilepsy Across the
Spectrum: Promoting Health and Understanding (2).
The report emphasized that epilepsy is a common spectrum of dis-
orders  that  affects  not  only  health  but  also  quality  of  life  for
people of all ages; that a more coordinated approach is needed for
care centering on the whole patient; that although effective treat-
ments are available, timely referral and access to treatments fall
short; and that it is an area filled with complexity and stigma. To
address these and other challenges, the IOM recommended ac-
tions for a wide range of stakeholders in 7 domains (Table) (2).
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For HHS, the IOM report  served as a catalyst  for accelerating
projects under way, launching new ones, and integrating depart-
mental efforts (2,7). In 2 years since the report was released, HHS
agencies have implemented numerous recommendations, often in
collaboration with community partners and also by building on
initiatives in the Affordable Care Act (ACA). This article docu-
ments these HHS efforts; of the 7 domains for which the IOM re-
commended actions, HHS has bolstered efforts in the first 5 do-
mains, and in the remaining two has furthered partnerships with
the voluntary, nongovernmental sector (through grants, contracts,
or memoranda of understanding). The Table summarizes selected
HHS activities, and we provide more information by domain be-
low.
Increasing the Power of Epilepsy Data
The IOM report urged validation and implementation of standard
definitions and criteria throughout all  aspects of epilepsy care,
treatment, and prevention as well as expansion of data collection
and surveillance efforts.
Standard definitions
The  National  Institute  of  Neurologic  Disorders  and  Stroke
(NINDS) recently led the Common Data Element Project, which
now standardizes the collection of epilepsy data by using com-
mon definitions and terminology throughout the National Insti-
tutes of Health (NIH) and for researchers nationwide. This stand-
ardized format should lead to common documentation, allow in-
corporation of epilepsy into clinical research on related conditions
(such as traumatic brain injury and neurodevelopmental condi-
tions),  and facilitate  data  collection.  Dissemination of  this  re-
source may foster universal adoption by epilepsy researchers and
help them to reduce study start-up time, improve data quality, and
promote data sharing across clinical research studies (8).
Prevalence data and national goals
The IOM report stimulated new Centers for Disease Control and
Prevention (CDC) efforts to clarify the burden of epilepsy in the
United States. After the 2012 IOM report release, the CDC epi-
lepsy program published updated figures on national prevalence
(for the first time since 1994) using data from the 2010 National
Health Interview Survey (NHIS), the flagship HHS survey that as-
sesses some 42,000 households annually (9,10). Using validated
questions for identifying clinical cases of epilepsy among com-
munity-dwelling adults, the analysis found that an estimated 4.1
million adults reported having epilepsy at some point in their life-
time (defined as being told by a physician or other health profes-
sional that they have epilepsy), while 2.3 million of them reported
having active epilepsy (defined as having physician-diagnosed
epilepsy and taking medications for seizures or having ≥1 seizures
in the previous year) (9). The study documented that among adults
with active epilepsy, only 52.8% had seen a neurologist or epi-
lepsy specialist in the previous year, suggesting suboptimal care
and problems with access (9).
A federal interagency workgroup used these NHIS epilepsy data to
develop the first objective on epilepsy in Healthy People, the pub-
lic health initiative that has set 10-year goals and objectives for the
nation each decade since 1979. These new 2010 data meet Healthy
People 2020 objective criteria that ensure continuity and compar-
ability of data over time and allow the country to set and track pro-
gress toward national targets for epilepsy into the 21st century (see
“Improving Epilepsy Care” below) (11).
In addition to these national analyses, CDC has committed to ex-
panding state, regional, and tribal (ie, American Indian communit-
ies) estimates of the burden of epilepsy (3,12,13). For example,
the South Carolina Epidemiologic Study of Epilepsy is examining
the burden of epilepsy (including rates of comorbidity, health care
use, and early mortality) in that state (14). Investigators are identi-
fying epilepsy cases with International Classification of Diseases,
9th revision, Clinical Modification (ICD-9-CM) codes (eg, 345.x)
in a statewide administrative database that captures data on 2 mil-
lion patient encounters for about 409,000 people with epilepsy
(2000–2011). Using these data, a 2014 study found that about 57%
of people with epilepsy (and only about 28% of controls) had both
somatic and psychiatric/neurodevelopmental comorbidities (14).
Comorbidities
By urging broader attention to documentation of epilepsy comor-
bidities, the IOM report supports the HHS Strategic Framework
for Multiple Chronic Conditions,  which emphasizes a patient-
centered approach to care coordination (15). In this regard, CDC
released a 2013 study of NHIS data (2010) to describe the burden
of nonpsychiatric comorbidities in adults with epilepsy (16). Such
adults were more likely than those without the condition to have 4
or more comorbidities (eg, cardiovascular disease, respiratory dis-
orders) that reflect shared disease mechanisms, treatment side ef-
fects, and higher rates of risk factors (eg, cigarette smoking, phys-
ical inactivity) (16).
CDC also incorporated examination of epilepsy as a co-occurring
condition into its existing cerebral palsy surveillance activities.
Since its 2006 surveillance year, CDC has used its Autism and De-
velopmental Disabilities Monitoring (ADDM) Network to track
the co-occurrence of  epilepsy among 8-year-old children with
cerebral palsy in 4 US communities; 35% in 2006 and 41% in
2008 had co-occurring epilepsy (17,18). The methods built on a
feasibility study at the Missouri ADDM Project that assessed the
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co-occurrence of epilepsy among children with cerebral palsy and
autism spectrum disorder (ASD); 32.9% of children with cerebral
palsy and 8.7% of children with ASD also had epilepsy (19).
Epilepsy-associated mortality
Despite overall mortality rates among people with epilepsy 3 times
higher than rates among people in the general population and sud-
den death risk 20 times higher (20), no US surveillance system
had previously monitored sudden unexpected death in epilepsy
(SUDEP). In 2013, with support from the NIH’s National Heart,
Lung, and Blood Institute (NHLBI) and NINDS, CDC expanded
its Sudden Unexpected Infant Death Case Registry to develop the
new Sudden Death in the Young (SDY) Registry. The SDY re-
gistry will identify both SUDEP and sudden cardiac deaths among
children and young adults aged 19 years or younger, consistent
with  child  death  review systems and protocols  in  most  states.
Funding in 2014 will support participation of up to 15 states or
major metropolitan areas in the registry (21). Registry data could
allow researchers  to  identify  preventable  risk  factors  or  other
mechanisms that may cause SUDEP.
Also,  to  expand surveillance  of  epilepsy-associated mortality,
CDC is examining the National Vital Statistics System’s all-cause
mortality files to identify possible cases of SUDEP among adults
and also analyzing the National Violent Death Reporting System
to clarify the rates of suicide among people with epilepsy.
Preventing Epilepsy
In response to the IOM report’s call for more investigation that
could lead to better primary, secondary, and tertiary prevention,
HHS has moved toward more unified planning in that regard. For
example, the Interagency Collaborative to Advance Research in
Epilepsy (ICARE) joins NIH agencies, Vision 20–20, IOM, and
key epilepsy stakeholder organizations, such as Citizens United
for Research in Epilepsy (CURE), to promote research. Estab-
lished several years ago, ICARE now uses the IOM report recom-
mendations as a framework for its meetings, which bring more re-
search attention to conditions beyond seizures that commonly af-
fect epilepsy patients (including ASD, developmental and intellec-
tual disabilities, cognitive impairment, and mental health condi-
tions).  In  support  of  these  efforts,  NINDS  has  updated  2014
Benchmarks for Epilepsy Research to encourage fuller explora-
tion  of  the  relationship  of  comorbidities  with  epilepsy  and
seizures, underlying disease mechanisms, and effects of epilepsy
treatment (22).
NIH recently established the NIH NeuroBioBank, which coordin-
ates human brain and tissue repositories. The NeuroBioBank web-
site provides information about the donation process and about
how postmortem tissue research can advance knowledge about
brain disorders (23). President Obama’s new BRAIN (Brain Re-
search through Advancing Innovative Neurotechnologies) initiat-
ive, which includes 6 new NIH funding opportunities, encourages
the formation of interdisciplinary teams to develop new noninvas-
ive imaging technologies for human research and advances tech-
nological capabilities for understanding how circuits of interact-
ing neurons function to create behavior (24).
Primary prevention and basic research
NIH-funded research could lead to improved prevention by identi-
fying biomarkers of epileptogenesis in populations at risk (includ-
ing those with tuberous sclerosis complex and traumatic brain in-
jury and children with prolonged febrile seizures).  The Epi4K
multisite  international  collaboration funded by NINDS, which
analyzes the genomes of more than 4,000 individuals with epi-
lepsy and their families, recently identified new gene mutations as-
sociated with infantile  spasms and Lennox–Gastaut  syndrome
(25), 2 severe forms of childhood-onset epilepsy associated with
intellectual and developmental disabilities. Moreover, some re-
cent research suggests congenital human papillomavirus infection
could be a cause of epilepsy due to cortical dysplasia (26). Also,
the National Institute of Child Health and Development’s Neonat-
al Research Network has helped develop standardized protocols
involving head cooling in neonates with hypoxic-ischemic brain
injury to reduce neurological impairments and mortality (27).
Secondary and tertiary prevention: chronic disease
self-management and drug and device interventions
The IOM report calls attention to epilepsy self-management (2), a
theme reinforced by the ACA’s attention to patient chronic dis-
ease self-management (CDSM). CDSM entails improving know-
ledge and problem-solving skills in self-management so that pa-
tients can be full partners in their own care. In particular, the IOM
report recognized research under way since 2007 by the CDC’s
Prevention Research Centers’ Managing Epilepsy Well (MEW)
Network (28).
Three self-management programs have been designed with the
goals of improving self-management behaviors, reducing depres-
sion, improving quality of life, and eliminating barriers to care (eg,
transportation, stigma, functional impairments) (28). WebEase
(Epilepsy Awareness Support and Education), the first evidence-
based online self-management program for adults with epilepsy
(29), is available without cost on the national Epilepsy Founda-
tion website (http://www.webease.org). Project UPLIFT (Using
Practice  and  Learning  to  Increase  Favorable  Thoughts)  and
PEARLS (Program to Encourage Active Rewarding Lives) offer
treatment for depression in adults with epilepsy, delivered by tele-
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phone, Internet, or home visits (30,31). UPLIFT and PEARLS in-
tervention protocols are available at no cost to providers, but train-
ing for both programs is recommended. Since 2013, CDC has col-
laborated with the national Epilepsy Foundation to support evalu-
ation of Project UPLIFT in Florida, Michigan, and New York.
MINDSET (Management Information and Decision Support Epi-
lepsy Tool) is a decision-support tool for use in clinics to improve
patient–provider  communication  about  self-management  (32).
Other MEW Network self-management programs under evalu-
ation focus on enhancing social support and mood and cognitive
management among adults and will report outcomes by late 2014.
Since the IOM report release, CDC has expanded its MEW Net-
work from 4 to 6 university-based sites to evaluate self-manage-
ment programs for adults with epilepsy and memory problems,
adults with epilepsy and serious mental illness (eg, schizophrenia),
and adults with epilepsy who live in rural areas. A request for pro-
posals issued in March 2014 supports replication studies and cost-
effectiveness studies of MEW Network programs and the develop-
ment of new self-management programs in vulnerable groups (eg,
children with epilepsy).
In the realm of devices and drugs for possible secondary and ter-
tiary prevention, the Food and Drug Administration (FDA) an-
nounced in 2013 approval of a cranially implanted neurostimulat-
or, which reduces seizure frequency (in people aged ≥18 years)
with partial onset seizures refractory to 2 or more antiepileptic
medications (33). FDA also has studies of drugs and devices relev-
ant to epilepsy, including protocols examining bioequivalence of
generic formulations of brand-name seizure medications in head-
to-head comparisons.
Improving Health Care
Although effective treatments are available for some people with
epilepsy, too many lack access to specialist care, insurance cover-
age, care coordination, and quality care and treatment. The IOM
report recommends earlier identification of epilepsy and its comor-
bidities, greater focus on quality of care, stronger epilepsy net-
works including epilepsy centers, and enhanced professional edu-
cation.
Access to specialist care and insurance coverage
Although many people with epilepsy may be treated effectively by
primary care physicians, those with uncontrolled seizures require
more specialized care provided by a neurologist or epilepsy spe-
cialist. People with uncontrolled seizures are at higher risk for ad-
verse outcomes such as unemployment, driving limitations, loss of
independence, and early mortality. A study of 13 states found that
34.9% of adults with active epilepsy and uncontrolled seizures in
the previous 3 months did not see a neurologist or an epilepsy spe-
cialist in the previous 12 months, and about 20% of adults with
epilepsy reported cost as a barrier to seeking care (3). On the basis
of 2010 NHIS data, Healthy People 2020 now includes as a na-
tional goal to increase the proportion of people with epilepsy and
uncontrolled seizures (defined as people who reported being told
by a doctor or health provider that they have epilepsy and repor-
ted ≥1 seizures of any type in the previous year) who receive ap-
propriate care (ie, see a neurologist or epilepsy specialist at least
once per year) from a baseline of 57.7% (in 2010) to 63.5% (in
2020) (11).The ACA prohibits insurance companies from refusing
to sell or renew policies because of pre-existing conditions such as
epilepsy (34). It also prohibits lifetime and annual dollar limits of
health insurance coverage, thereby greatly reducing risks of med-
ical  bankruptcy for  individuals.  Improved insurance coverage
could help improve access to specialist care. Because epilepsy is
often a condition in children and young adults, it is noteworthy
that at least 3.1 million young adults younger than 26 have ob-
tained insurance coverage through their parents’ health plans since
2010 (35). Young adults have also accessed new coverage through
Medicaid expansion and the ACA marketplaces.
Additionally, the provision of mental health coverage as part of es-
sential health benefits made available through the ACA could also
improve care for the large numbers of people with epilepsy and
comorbid mental illness (2).
Care coordination
The ACA authorizes demonstration projects to promote care co-
ordination and team-based approaches to care delivery. In this
spirit,  the  Health  Resources  and  Services  Administration’s
(HRSA’s) Maternal and Child Health Bureau funds Project Ac-
cess, which focuses on improving access to coordinated, compre-
hensive care for children and teens with epilepsy in medically un-
derserved and rural areas. Consistent with IOM recommendations,
these state and community-based demonstration projects, suppor-
ted by a coordinating center at the American Academy of Pediat-
rics,  promote  patient/family–professional  partnerships;  link
primary and specialty care, educational services, public health, and
other community resources; focus on early detection and treat-
ment; and address cultural and linguistic barriers to care.
Quality of care
In its third round of funding  in 2013, Project Access commits to
quality measurement and the use of quality improvement methods
(based  on  the  Institute  for  Healthcare  Improvement’s  Break-
through Series Model) to implement and validate a well-function-
ing community-based system of services for children and teens
with special health care needs (36). As part of this process, the co-
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ordinating center and the new 2013 grantees will assess outcomes
such as family satisfaction with professionals, levels of continu-
ous  coordinated  care  in  a  family-centered  medical  home,  and
whether families have adequate insurance to pay for services.
Expanding the evidence base on quality and documenting pos-
sible cost savings could lead to new payment models. As part of
the ACA, the Centers for Medicare & Medicaid Services (CMS)
enhanced support for care coordination in numerous areas. Also, a
recent change in Medicaid rules allows for reimbursement for pre-
ventive services by qualified professionals established by the state
if the service is recommended by a physician or other licensed
practitioner (37). States have the authority to allow licensed practi-
tioners to deliver care in nonclinical settings, such as in homes or
schools. The CMS Innovation Center, created by the ACA, serves
as a new locus to foster innovative care-delivery models seeking
to improve quality and reduce costs.
Epilepsy networks
The University Centers for Excellence in Developmental Disabilit-
ies (UCEDDs) (38), a national network funded by the HHS Ad-
ministration for Community Living, supports individuals with in-
tellectual and developmental disabilities, approximately 40% to
50% of whom have seizures. The Administration for Community
Living funds 68 UCEDDs — at least one in every state and territ-
ory — to provide interdisciplinary training, community service,
research, and information to increase independence, community
integration, and inclusion of individuals with developmental and
other disabilities (38). Each UCEDD develops its own priorities.
Several, including UCEDDs in New York and Nebraska, have pri-
oritized provision of clinical services for seizure control. Another,
at  the  Westchester  Institute  for  Human  Development  in  New
York, aims to reduce polypharmacy for epilepsy patients. Still oth-
ers, such as the UCEDDs in Alaska, Washington, and Nevada, and
at the University of Southern California, with HRSA funding have
collaborated to improve outreach and access to care for individu-
als in rural areas.
Telemedicine and telehealth to improve access
Some Project Access grantees and UCEDDs are using telemedi-
cine and telehealth as a way to extend access to quality care and
improve outcomes in rural and underserved areas. Telemedicine
can overcome the physical distance between the care site and the
health care expert to connect patients and their families, primary
care practitioners, and epilepsy specialists in a patient-centered
medical home, enhance real-time monitoring of test results and
scans, and deliver health professional education. Early data from
West  Virginia,  Michigan,  and Nebraska indicate reduced wait
times for neurology visits and less time and money spent by famil-
ies  traveling  to  specialist  visits.  In  particular,  the  Nebraska
UCEDD, as a Project Access grantee, was preliminarily able to re-
duce the wait time for telehealth consultation appointments for
children; more formal evaluation of this program is needed. Also,
the IOM report has spurred regional planning, including telecom-
munication technology options, in the 4-state region of Kansas,
Nebraska, Iowa, and Missouri, which has almost 14 million people
but only a few epileptologists.
Professional education
Professional education can involve many types of providers, in-
cluding primary care providers, school nurses, first responders,
and  law-enforcement  personnel.  These  professionals  can  be
trained to provide appropriate care and help link people with epi-
lepsy to community supports. For example, the CDC-supported
Epilepsy Foundation program, Managing Students with Seizures,
trains school nurses about epilepsy and the needs of students with
epilepsy. An evaluation of this program demonstrated increased
confidence among nurses across numerous domains (eg, the abil-
ity to recognize partial seizures, knowing when to contact emer-
gency help) (39). Another CDC-supported educational program
implemented by Epilepsy Foundation affiliates across the country
teaches first responders to identify the various symptoms associ-
ated with seizures, provide appropriate first aid response on scene,
and determine situations warranting further medical care.
Similarly, CDC-supported law-enforcement training programs aim
to improve recognition of seizures and awareness of the unique
needs of people with epilepsy who may otherwise be subjected to
physical restraint and be taken into police custody. Other CDC-
supported training programs in local communities focus on child
day care staff, adult day care staff, and middle- and high-school
students and teachers. Initial evaluation results from these educa-
tional programs are promising, but additional studies are needed
(6).
Improving Community Resources and
Quality of Life; Raising Awareness, and
Improving Education
Beyond seizures, the impact of epilepsy involves challenges in
schools,  uncertainties about social  and employment situations,
limitations on driving, and questions about independent living. To
address these needs, the IOM report urges improving community
resources and improving education for people with epilepsy, their
families, and the public.
PREVENTING CHRONIC DISEASE                                             VOLUME 11, E146
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY                                                    AUGUST 2014
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
                                    the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2014/14_0270.htm • Centers for Disease Control and Prevention       5
Patient and provider education
The CDC MEW Network provides free webinars and podcasts to
patients, their caregivers, and health and social service providers
about the benefits of epilepsy self-management. Since 2012, CDC
has also supported provider training for UPLIFT (at no cost) and
PEARLS with professional certification credits.
Public education
CDC continues to partner with the Epilepsy Foundation to con-
duct public education and awareness campaigns (6). Although im-
provements in negative attitudes toward epilepsy have been repor-
ted over the decades (40), in 2002 about one-half of US adults be-
lieved that they were not knowledgeable about epilepsy, and only
about  40%  believed  they  knew  what  to  do  if  someone  had  a
seizure (2). In 2006, a study found that more than 80% of US com-
munity-dwelling adults disagreed with negative stereotypes of
people with epilepsy (41),  but substantial  proportions of these
adults expressed concerns about seizures,  suggesting potential
avoidance behaviors associated with perceptions of risk (41,42).
Epilepsy Foundation outreach campaigns that previously focused
on African Americans and Hispanic Americans were extended in
2013 to Asian Americans. With combined English- and Chinese-
language media in targeted US markets (Hawaii, Ohio, Oregon,
Texas, Washington), the foundation’s Asian American outreach
campaign  reached  almost  an  estimated  3  million  people  (P.
Katana, oral communication, 2013). More formal evaluation is
needed.
Strengthening Stakeholder Collaboration
and Engaging People With Epilepsy and
Their Families
The last 2 domains from the IOM report highlight the critical roles
of epilepsy stakeholders — including people with epilepsy and
their families — in fostering and sustaining public health action
(2). Organizing frameworks for stakeholder collaboration exist
through  various  groups,  including  the  Vision  20–20  working
groups (2), the CDC MEW Network, the NINDS ICARE, Project
Access, and the UCEDDs. Key groups such as CURE have ad-
vanced collaboration in vital ways. Participation of the broader
public health community can support the IOM recommendations,
elevate epilepsy as a public health issue, educate all about the new
operational definitions for epilepsy (43), and potentially improve
the lives of the millions of people living with epilepsy.
Conclusion
The 21st century is the time for a more integrated public health ap-
proach to epilepsy. People with epilepsy need better coordinated
care, social support, and treatments and greater social acceptance.
The convergence of HHS and nonfederal partner interest has not
only yielded a major public health roadmap through the 2012 IOM
report but also accelerated the integration of activities through
HHS agencies and nongovernmental partners.
Implementation of the IOM report recommendations stimulated
activities to improve understanding of the burden of epilepsy, es-
tablish new surveillance systems for SUDEP, renew attention to
comorbidities, accelerate new models for care coordination in the
era of the ACA, explore improved outreach through telehealth, in-
crease emphasis on improved access and quality of care, heighten
collaboration on research for better prevention, and improve pub-
lic  and  professional  education  for  an  array  of  stakeholders.
Moreover, the country established targets for epilepsy as part of its
Healthy People 2020 process, which can monitor progress for the
future.
Although the challenges ahead are considerable, these and future
activities, in close collaboration with community-based partners
and others, can bring renewed understanding of epilepsy as a pub-
lic health priority. Continued commitment and momentum can
move the country closer to a true integrated public health system
for epilepsy for the 21st century.
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Table
Table. Selected Department of Health and Human Services (HHS) Activities Following the Release of the Institute of Medicine
(IOM) Report Epilepsy Across the Spectrum: Promoting Health and Understanding (2012)
IOM Domain and Recommendations Selected HHS Activitiesa
Increasing the power of epilepsy data
1. Validate and implement standard definitions and criteria
for epilepsy case ascertainment, health care and community
services use and costs, and quality-of-life measurement.
2. Continue and expand collaborative surveillance and data
collection efforts.
• Adoption of Common Data Element Project
• Expansion of national, state, and local surveillance systems to
examine epilepsy burden (eg, prevalence, access to care,
comorbidity, early mortality) in the general population and high-risk
groups
• Development and tracking of a national objective on epilepsy in
HHS Healthy People 2020 to track access to care
Preventing epilepsy
3. Develop and evaluate prevention efforts for epilepsy and
its consequences.
• Identification of biomarkers of epileptogenesis
• Identification of genetic factors that increase risk for epilepsy
• Advancement of technologies to elucidate brain functioning for
improved prevention and treatment opportunities
• Examination of bioequivalence of generic and brand-name seizure
medications
• Development and testing of chronic disease self-management
programs (secondary/tertiary prevention)
Improving health care
4. Improve the early identification of epilepsy and its
comorbid health conditions.
5. Develop and implement a national quality measurement
and improvement strategy for epilepsy care.
6. Establish accreditation of epilepsy centers and an
epilepsy care network.
7. Improve health professional education about the
epilepsies.
• Elimination of pre-existing condition exclusions in health insurance
policies and expanded coverage for care (eg, mental health care) via
Affordable Care Act
• Identification of promising practices of patient/family-centered
coordinated, comprehensive care for medically underserved children
and teens with epilepsy
• Improvement of clinical services for adults with epilepsy and
intellectual and developmental disabilities
• Expansion of telehealth/telemedicine services to reach people
living in rural and geographically isolated areas
• Support of professional training opportunities for providers on
epilepsy self-management
Improving community resources and quality of life
8. Improve the delivery and coordination of community
services.
• Implementation of evidence-based self-management programs for
community-dwelling people with epilepsy
• In partnership with the Epilepsy Foundation (national and state
affiliates), provision of community-based services, education, and
support to people with epilepsy and their caregivers
Raising awareness and improving education
Patient and family education
9. Improve and expand educational opportunities for
patients and families.
Public awareness and knowledge
10. Inform media to improve awareness and eliminate
stigma.
11. Coordinate public awareness efforts.
• Provision of free educational resources on epilepsy self-
management programs and resources to people with epilepsy and
their caregivers
• Provision of professional training opportunities for school nurses,
first responders, law enforcement, and other professionals to
improve their understanding of epilepsy
• In partnership with the national Epilepsy Foundation,
a Activities are organized primarily by IOM domains, but some activities overlap more than 1 domain.
(continued on next page)
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(continued)
Table. Selected Department of Health and Human Services (HHS) Activities Following the Release of the Institute of Medicine
(IOM) Report Epilepsy Across the Spectrum: Promoting Health and Understanding (2012)
IOM Domain and Recommendations Selected HHS Activitiesa
implementation of national and targeted public awareness
campaigns about epilepsy
Strengthening stakeholder collaboration
12. Continue and expand Vision 20–20 working groups and
collaborative partnerships.
• Collaboration in epilepsy stakeholder meetings, and other
communities of practice
• Expansion of partnerships with other clinical and public health
stakeholders
Engaging people with epilepsy and their families
13. Engage in education, dissemination of, and advocacy for
improved epilepsy care and services.
—
a Activities are organized primarily by IOM domains, but some activities overlap more than 1 domain.
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